City
Epaper

India to procure 27-28 crore COVID-19 vaccine doses in October: Sources

By ANI | Updated: September 30, 2021 19:05 IST

India would have 27-28 crore COVID-19 vaccine doses of Serum Institute of India's Covishield and Bharat Biotech's Covaxin in the month of October, said government sources.

Open in App

India would have 27-28 crore COVID-19 vaccine doses of Serum Institute of India's Covishield and Bharat Biotech's Covaxin in the month of October, said government sources.

27-28 crore COVID-19 vaccines doses that are to be procured do not include Biological E and Zydus Cadilla vaccines doses, sources told ANI.

Earlier in September, India has procured more than 25 crore doses of COVID-19 vaccine doses, added the sources had said.

Earlier,reported that the Centre plans to achieve the target of administering 100 crore COVID-19 jabs before the mid of October. The target of 100 crore doses administration is expected to be achieved between October 10 to October 12, stated the sources.

"Once we hit 100 crore dose, we are planning celebration across the country with COVID warriors, frontline workers and healthcare workers," said the sources.

The country has administered 88,34,70,578 vaccine doses so far under the nationwide vaccination drive, out of which 65,34,306 doses were administered in the last 24 hours.

On September 18, India set a world record by administering 2.5 crore COVID vaccine doses in a single day.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Bharat Biotech InternationalSerum Institute Of IndiaSerum institute of india pvt. ltdSerum indiaBharat biotech limitedBharat biotech international ltdBharat biotech companySerum institute of india private ltd.India serum institute of india
Open in App

Related Stories

PunePune Accident: Mercedes-Owned by Serum Institute of India Driver Arrested, Victims Kin Demands Justice

NationalCovaxin-Developer Bharat Biotech Amid Reports on AstraZeneca Vaccine, Says ‘Safety Is Primary Focus for All Our Vaccines’

NationalCovishield Vaccine Side Effect: Serum Institute Faces Legal Action As Parents of Deceased Girls Prepare Lawsuit

Social ViralCovishield Funny Memes Go Viral After AstraZeneca Admits Its COVID-19 Vaccine Can Cause Rare Side Effects

NationalSerum Institute founder Cyrus Poonawalla suffers cardiac arrest

National Realted Stories

NationalNo justification for such acts of terror: Iranian Prez condemns J&K attack in phone call with PM Modi

NationalPoster controversy: Police disperse protestors in Jaipur, say situation under control

NationalGujarat: Vadodara woman duped of Rs 5.61 lakh in visa scam, complaint filed

NationalRetaliatory actions against Pak reflect India’s strong policy against those promoting terror: Raksha Khadse

NationalMP: CM holds meeting on law and order, identified 228 Pak citizens to leave nation by Sunday